RT @EMA_News: 📢The CHMP recommends authorising a new treatment for early #AlzheimersDisease in the EU. Leqembi is intended for treatment….

To gather input for our revised guideline for treatment of epileptic disorders, we will organize a one-day workshop -29 Jan 2024. More info here:

To address the topic of effective and safe use of #psychedelics we are holding a multi-stakeholder workshop – "Towards an EU regulatory framework for psychedelics". Check out the agenda and the topics here:

EMA will host a Multi-stakeholder workshop on the guideline on clinical investigation of medicinal products in the treatment of epileptic disorders | European Medicines Agency via @EMA_News .Date:29/01/2024.Location:Online.

Our Guideline on Clinical investigation of medicinal products in the treatment of depression just published here: via @EMA_News.

What are the challenges and opportunities that #psychedelics present as potential treatments in #mentalhealth disorders: see the position of KOLs in #regulatory #neuroscience in this collaborative work

On the World Duchenne awareness day #WDAD2022 let's remember that only by working together we can hope to find a brighter future. Share the word. Raise awareness.

RT @EMA_News: EMA started the evaluation of applications for adapted versions of Comirnaty and Spikevax. #COVID19vaccines.

RT @euronews: If taken in the first days of COVID symptoms appearing, the new antiviral drug could reduce hospitalisations and death in at-….

RT @EMA_News: EMA recommends authorising the oral antiviral #Paxlovid for treating #COVID19 in adults who do not require supplemental oxyge….

RT @EMA_News: EMA recommends granting a marketing authorisation in the 🇪🇺 for Trodelvy, a first-in-class #medicine to treat an aggressive f….

RT @EMA_News: EMA has published the clinical data supporting the conditional marketing authorisation of Vaxzevria, previously #COVID19Vacci….

RT @EMA_News: It seems that the 4 vaccines authorised in the EU 🇪🇺 protect against all strains, including the delta variant. First real-wor….

RT @EMA_News: EMA’s human medicines committee (#CHMP) recommends 8 #medicines for approval at its May 2021 meeting:.

RT @EMA_News: EMA is monitoring very closely the data on the Indian variant. We are seeing promising evidence that mRNA vaccines would be a….

RT @EMA_News: EMA has started a rolling review of data on sotrovimab (also known as VIR-7831 and GSK4182136) a monoclonal antibody develope….

RT @EMA_News: EMA’s safety committee (#PRAC) is continuing its evaluation of very rare cases of unusual blood clots in people vaccinated wi….

EMA: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets | European Medicines Agency via @EMA_News.

RT @EMA_News: The vaccine from Janssen-Cilag International N.V. is currently under rolling review. A date for submission of a marketing aut….

RT @EMA_News: After having received more data from the company, EMA is expecting Astra Zeneca to submit a conditional marketing application….